Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85457569 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY
• Document 79147892 overview

---

---

The "UPERIO" trademark, serial number 85457569 , was filed on 27th of October 2011 with a mark drawing code of 4000 and its transaction date is 85457569. Since 22nd of May 2012, the document can be found in the M10 law office in the publication and issue section. The employee responsible is VOHRA, SANJEEV KUMAR and the date it was published for opposition on 03/27/2012. The status of this trademark was checked last on 05/22/2012.

The corresponded responsible for this trademark is MAURY M. TEPPER, III, located at TEPPER & EYSTER, PLLC, 3724 BENSON DR, RALEIGH, NC 27609-7321.

The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at Ch-4002, Basel, zip .Other trademarks by this applicant: E-MERG PEN JUNIOR, GO PROGRAM, CIBA VISION.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	10/31/2011
Primary Code	005
Goods codes
GS0051	Anti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases

PROSECUTION HISTORY
Date	Description	Type	Code
05/22/2012	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	E	NOAM
03/27/2012	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
03/27/2012	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
03/07/2012	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	E	NONP
02/21/2012	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
02/17/2012	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
02/02/2012	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2012	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
10/31/2011	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
10/31/2011	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.